Helen presents at RCPath Industry Leaders’ Forum
She delivered her presentation alongside now former Health Innovation Minister Zubir Ahmed MP and Dr Rhydian Phillips, Director of Diagnostics and Transport at NHS England.
Headlines
MHRA publishes draft Pre-Market Statutory Instrument and seeks views via survey
BIVDA broadly welcomes the publication, which provides an important indication of the future direction of the UKMDR and demonstrates continued progress towards greater international harmonisation.
Helen participates in parliamentary panel and roundtable on AI and innovation
She spoke alongside the likes of host, Cambridge MP Daniel Zeichner, and Professor Gillian Leng, underlining the need for greater innovation adoption in the NHS.
Membership News
Be part of the UK-India Diagnostics Cohort 2026 this October
Supported by the Department for Business and Trade and Health Innovation Yorkshire and Humber, companies have the opportunity to explore India’s healthcare market across a 5-day visit.
Chinese manufacturer seeking distribution partnership with UK companies
Following on from BIVDA’s role in the government’s IVD mission to China, we have been contacted by a Chinese manufacturer, Shanghai GeneoDx Biotech. If interested, please email ben.kemp@bivda.org.uk.
BIVDA Survey: provide views on medical devices regulations
DHSC has launched a request for stakeholder input as part of its statutory report under the Medicines and Medical Devices Act 2021. This report assesses how the regulations made under the Act are operating in practice.
UKDI: £2m funding for solving Biosecurity Frontiers challenges
These challenge funding competitions seek solutions in biodetection and biosurveillance, AI and diagnostics, therapeutics and vaccines, and non-pharmaceutical protective systems.
Attend BIVDA’s Innovation Working Party on Tuesday 19th May
Topics for discussion will be navigating the UK innovation pathway and challenges facing emerging IVD companies in the UK.
Do you conduct bioanalysis? Help the National Measurement Laboratory better understand global measurements made by our sector
Through questionnaires, NML seek to understand what measurements you are making and what units you use.
At-home blood test could predict Alzheimer’s risk
Researchers from the University of Exeter have found that an at-home blood test – combined with an online brain assessment – can predict a person’s risk of developing Alzheimer’s.
BIVDA Webinar: What could quantum sensing mean for the future of IVDs?
BIVDA members are invited to join experts from the Q-BIOMED hub for an interactive session on Tuesday 16th June at 1pm – 2pm on how quantum sensing technologies could reshape the way disease is detected, measured, and understood across clinical pathways.
BIVDA member’s rapid stroke test to be piloted in London ambulances
We would like to congratulate BIVDA member Upfront Diagnostics, who have officially launched their LVOne stroke test in the UK, which is set to be piloted across London, and have also been featured in The Times.
BIVDA welcomes new member TÜV Rheinland UK Ltd
TÜV Rheinland stands at the forefront of global efforts to ensure the quality and safety of technology and the environment for society.
GAIL – Helping Your Members Navigate Geopolitical Risk
GAIL – an exciting new geopolitical risk management platform – will run a webinar to showcase its capabilities on Wednesday, 3rd June at 12:30.
Free upcoming event: Femtech, Innovation and Diagnostics for Women’s Health
Next month in London, the Centre for Advanced Diagnostics Development and Application (CADDA) host their Femtech, Innovation and Diagnostics for Women’s Health event on Thursday 18th June, at the UCL building on Guilford Street.
Government cuts electricity bill for 10,000 manufacturers
The final design of the British Industrial Competitiveness Scheme (BICS), first announced in last year’s Modern Industrial Strategy, means the scheme will be expanded to cover an extra 3,000 businesses.
Can you provide work experience for a week in June?
BIVDA have been contacted by a 16-year old GCSE student who is keen to work in healthcare in future, specifically pathology, who is seeking a one-week of work experience from 29th June to 3rd July 2026.
National AI Commission: Ask Me Anything – 20th May
The MHRA are hosting a live Ask Me Anything on Wednesday 20 May 2026 at 9:30am – 10:30am on how artificial intelligence (AI) is being regulated in healthcare.
Attend the MedTech Summit on 15–18 June 2026
Are you ready to navigate the complexities of EU MDR, IVDR, SaMD, AI, and global markets? The MedTech Summit 2026 is your ultimate destination for actionable insights, regulatory guidance, and unparalleled networking opportunities.
Media Monitoring: 30th April – 13th May
A round-up of the week’s best diagnostics-related news.
Member Requests
REMINDER: We encourage members to send us relevant material – including events, conferences and workshops – to share on the newsletter. Please send them to ben.kemp@bivda.org.uk.
Are you producing or preparing to produce a point-of-care test (fingerstick sample) for vitamin D, ideally quantitative? We have had a request to find members who might have a suitable test to use in an acute paediatric setting. Please send an email to Lucy.Lehane@bivda.org.uk with your info!
Member seeks R&D space in in Bath or Bristol to develop a proof of concept for an assay
If you are able to help, please email kaye.walton@bivda.org.uk.
Member seeking partnerships with tech companies creating remote digital or AI UTI tests
Forte Medical are seeking partnerships with tech companies creating remote digital or AI UTI tests, for an early dialogue around their work to flat-pack Peezy Midstream.
The product is also ready to market for HPV, STI and some early stage cancer diagnoses.
If you are a remote testing company or laboratory with urine-based diagnostic tech and want to provide hygiene and dignity as well as accuracy to your customers, please email: giovanna.forte@forte-medical.com.
Efficient and Effective Smart Bio-Affinity Reagents – an alternative to using antibodies
At the University of Central Lancashire, Professor Sub Reddy’s Group has developed a proprietary, scalable technology to custom-produce high-affinity reagents—powerful alternatives to traditional antibodies. These reagents are designed to selectively isolate proteins and viruses, an innovation they believe could have a huge impact on industries ranging from biotech to diagnostic applications.
They are currently exploring commercialisation opportunities, including spin-out and licensing options, and have launched a survey and landing page to test the market. If you’re interested in learning more, check out polymimix.com to share your feedback. If you have any questions, please email: smreddy@uclan.ac.uk
Events Diary
BIVDA Infectious Diseases & Near Patient Testing Working Party (Combined)
Date: Thursday 14th May 2026
Time: 10:30 – 13:00
Register Here
BIVDA Chemicals and Environmental Working Party – ONLINE
Date: Thursday 21st May 2026
Time: 10:30 – 13:30
Register Here